Drug intelligence / Profile preview

calcipotriene + triamcinolone acetonide

Development stage
Unknown
Lead developer
Sincerus
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Calcipotriene + triamcinolone acetonide is a topical combination drug consisting of calcipotriene, a synthetic vitamin D3 analog, and triamcinolone acetonide, a medium- to high-potency corticosteroid. Calcipotriene works by binding to the vitamin D receptor on keratinocytes, modulating gene expression and inhibiting their proliferation while promoting differentiation. Triamcinolone acetonide acts as an anti-inflammatory agent by suppressing the release of pro-inflammatory cytokines and mediators through glucocorticoid receptor activation. This combination is intended for use in inflammatory skin conditions such as psoriasis or other corticosteroid-responsive dermatoses where both reduction of inflammation and normalization of keratinocyte growth are desired[6][8]. The synergistic effect may provide enhanced efficacy compared to monotherapy with either agent.

02

Targets

GR (Glucocorticoid receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on calcipotriene + triamcinolone acetonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcipotriene + triamcinolone acetonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call